25 November 2016


Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology makes the following update on its block listing, pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies. All figures relate to options over ordinary shares of 0.2 pence each.

The table below provides further detail.

Name of company: Futura Medical plc
Name of scheme: Unapproved Share Option Scheme ("USOS")

EMI Share Option Scheme ("EMI")
Period of return: From: 20 May 2016
To: 24 November 2016
Number and class of securities not issued under the scheme(s) USOS: 1,440,600
EMI: 1,344,141
Total: 2,784,741
Number of securities issued under the scheme(s) during the period

Number of securities lapsed under the scheme(s) during the period (EMI adjustment to May return)
USOS: Nil
EMI:

USOS:
EMI:
Nil

(284,279)
20,000
Balance under the scheme(s) of securities not yet issued at the end of the period USOS: 1,156,321
EMI: 1,364,141
Total: 2,520,462
Number and class of securities originally admitted and the date of admission USOS: 814,424 on 25 May 2011 and 1,202,280 on 8 October 2013
USOS Total: 2,016,704
   
EMI: 1,520,576 on 25 May 2011 and 1,467,720 on 8 October 2013
EMI Total: 2,988,296
   
  Total: 5,005,000
Name of contact: Derek Martin, Chief Financial Officer
Telephone number of contact: +44 (0) 1483 685 670


 

For further information please contact:

Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.com
www.futuramedical.com

Nominated Adviser:
N+1 Singer
Aubrey Powell / Liz Yong / Thomas Smale
Tel: +44 (0) 20 7496 3000

For media enquiries please contact:

Buchanan Communications Limited
Mark Court / Sophie Cowles /
Stephanie Watson
Tel: +44 (0) 20 7466 5000